Aug 26, 2022 · Ondansetron oral solution is indicated for the prevention of post-operative nausea and vomiting (PONV)
Weight
The active ingredient in ZOFRAN ODT orally disintegrating tablets is
SUMMARY OF PRODUCT CHARACTERISTICS 1
Medicine Human Overview Emend is an antiemetic, a medicine that prevents nausea (feeling sick) and vomiting
Ondansetron is indicated for the management of chemotherapy-induced nausea and vomiting (CINV) in children aged ≥ 6 months, and for the prevention and treatment of
No studies have been conducted on the use
Ondansetron blocks the actions of chemicals in the body that can trigger nausea and vomiting
The intravenous dose must not exceed 8 mg
Ondansetron solution for injection/infusion is physically compatible and chemically stable when mixed with the following solutions for infusion over the concentration range of 0
QUALITATIVE AND QUANTITATIVE COMPOSITION 4 mg film-coated tablets One film-coated tablet contains 4 mg ondansetron (as ondansetron hydrochloride dihydrate)
Aloxi solution for injection has also been investigated in one study involving 502 children receiving chemotherapy that was a strong or a moderate trigger of nausea and vomiting, where Aloxi was compared with ondansetron
The SmPC is a legal document approved as part of the marketing authorisation of each medicine
Dosing by bodyweight: Weight-based dosing results in higher total daily doses compared to BSA-based dosing (sections 4
2 mg/kg/day every one to two weeks until optimal response is achieved, with a maximum maintenance dose of 400 mg/day
The description of the medicinal product’s properties and how it can be used
Ondansetron 4 Mg Film-Coated Tablets - Summary Of Product Characteristics (Smpc) -
1
≥ 0
Ondansetron orodispersible tablets contain lactose
29 The SmPC reports the following side effects: very common (> 10%): headache
Emetogenic chemotherapy and radiotherapy: Zofran can be given either by rectal, oral (tablets or syrup), intravenous or intramuscular administration
Ondansetron injection is contraindicated for patients known to have hypersensitivity (e
1 INDICATIONS AND USAGE